Cargando…
Techniques used for the discovery of therapeutic compounds: The case of SARS
Severe acute respiratory syndrome coronavirus (SARS-CoV) is the etiological agent of SARS disease, which has ever severely menaced humans from the end of 2002 to June 2003. To date, great efforts have been made for the discovery of therapeutic compounds by using various technologies. In this report,...
Autores principales: | Chen, Shuai, Chen, Lili, Chen, Kaixian, Shen, Xu, Jiang, Hualiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105914/ https://www.ncbi.nlm.nih.gov/pubmed/24980529 http://dx.doi.org/10.1016/j.ddtec.2006.09.005 |
Ejemplares similares
-
New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery
por: Tang, Yun, et al.
Publicado: (2006) -
The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1
por: Luo, Haibin, et al.
Publicado: (2005) -
Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase N Terminus Is Indispensable for Proteolytic Activity but Not for Enzyme Dimerization: BIOCHEMICAL AND THERMODYNAMIC INVESTIGATION IN CONJUNCTION WITH MOLECULAR DYNAMICS SIMULATIONS
por: Chen, Shuai, et al.
Publicado: (2005) -
Mutation of Gly-11 on the Dimer Interface Results in the Complete Crystallographic Dimer Dissociation of Severe Acute Respiratory Syndrome Coronavirus 3C-like Protease: CRYSTAL STRUCTURE WITH MOLECULAR DYNAMICS SIMULATIONS
por: Chen, Shuai, et al.
Publicado: (2008) -
Severe acute respiratory syndrome coronavirus membrane protein interacts with nucleocapsid protein mostly through their carboxyl termini by electrostatic attraction
por: Luo, Haibin, et al.
Publicado: (2006)